Anti-Ku Antibody-Positive Myositis Presenting as a Wide Range of Axial Myopathies and Myocarditis: A Case Report and Review of the Literature.
Masanori KonoToshihiko KomaiHayato YukiNorio HanataToshiyuki KakumotoAkatsuki KubotaMeiko Hashimoto MaedaTatsushi TodaHirofumi ShodaKeishi FujioPublished in: Modern rheumatology case reports (2021)
Idiopathic inflammatory myopathies (IIMs) are autoimmune diseases predominantly affecting proximal muscles; paraspinal muscle involvement is relatively rare. Because paraspinal myopathies do not always cause clinically-evident symptoms, the diagnosis of IIMs with axial myopathies can be challenging. Anti-Ku autoantibodies, initially reported in polymyositis/systemic sclerosis overlap syndrome, are myositis-associated antibodies (MAAs) observed in patients with a wide variety of connective tissue diseases (CTDs). Few reports have been published demonstrating predominant axial myopathy in IIM patients with anti-Ku antibodies. Herein, we investigated a previously healthy Japanese woman in her early 70s who presented with Raynaud's phenomenon, back pain, and exertional dyspnea. The creatine kinase (CK) was elevated and antinuclear antibody staining was positive, but myositis-specific antibodies (MSAs) were negative. Magnetic resonance imaging (MRI) revealed myocarditis and a wide range of axial muscle inflammation, including bilateral thoracolumbar paraspinal, infraspinatus, and trapezius muscles. The muscle biopsy was consistent with IIM. In addition, anti-Ku antibody was positive. Administration of prednisolone and tacrolimus quickly alleviated the symptoms and the CK level returned to normal. The diagnosis of IIM was arduous in this case because she did not present with camptocormia, muscle weakness involving the proximal limbs was not apparent, and MSAs were negative. Whether axial myopathy and myocarditis are more prevalent in IIM patients with than without anti-Ku antibodies is uncertain. Clinicians should suspect axial myopathy and MAAs, such as anti-Ku antibodies, especially in patients in whom muscle weakness of the proximal limbs is not noticeable.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- magnetic resonance imaging
- skeletal muscle
- oxidative stress
- myasthenia gravis
- end stage renal disease
- protein kinase
- rheumatoid arthritis
- palliative care
- newly diagnosed
- chronic kidney disease
- computed tomography
- physical activity
- contrast enhanced
- high resolution
- depressive symptoms
- systemic lupus erythematosus
- magnetic resonance
- ultrasound guided
- prognostic factors
- mass spectrometry
- single cell
- peritoneal dialysis
- atomic force microscopy
- sleep quality